Camp4 Therapeutics Corp. (CAMP) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Camp4 Therapeutics Corp. (CAMP:NASDAQ), powered by AI.

Current Price
$4.19
Sector
Healthcare
What is the Camp4 Therapeutics Corp. stock price forecast?

Camp4 Therapeutics Corp. is currently trading at $4.19. View real-time AI analysis on Alpha Lenz.

What is Camp4 Therapeutics Corp. insider trading activity?

View the latest insider trading data for Camp4 Therapeutics Corp. on Alpha Lenz.

What is Camp4 Therapeutics Corp.'s P/E ratio?

View Camp4 Therapeutics Corp.'s valuation metrics on Alpha Lenz.

Camp4 Therapeutics Corp.

NASDAQ · CAMP
$4.19-0.03(-0.71%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Camp4 Therapeutics Corp.'s future dividend policy...
Alpha Chat Insight

Camp4 Therapeutics Corp.'s ROE is -145.1%. Explore profitability and growth together.

Ask for details

Company Overview

Camp4 Therapeutics Corp. is a biotechnology company focused on developing innovative therapeutics by unlocking the potential of gene regulation. The company's core mission is to harness the knowledge of transcriptional machinery and regulatory RNA maps, pioneering in the precision medicine landscape. Camp4 Therapeutics targets a wide array of conditions, primarily genetically driven diseases, by delicately manipulating gene expression to restore normal cellular function. The firm's approach uniquely positions it to impact the broader healthcare and pharmaceutical industries significantly. By translating cutting-edge genomic insights into actionable therapeutic strategies, Camp4 aims to address unmet medical needs and enhance patient outcomes. The company's progress and pipeline developments are closely watched by stakeholders, reflecting its potential to contribute meaningfully to the biotech sector and ultimately, patient care.

CEOMr. Joshua Mandel-Brehm
SectorHealthcare
IndustryBiotechnology
Employees55

Company Statistics

FY 2025

Profile

N/AMarket Cap
$3.50MRevenue
0.00Shares Out
55Employees

Margins

N/AGross
-574.56%EBITDA
-1488.31%Operating
-2298.54%Pre-Tax
-2298.54%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-82.00%ROA
-145.07%ROE
-53.09%ROIC

Financial Health

$109.52MCash & Cash Equivalents
$-39.41MNet Debt
146.96%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Camp4 Therapeutics Corp. (ticker: CAMP) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 55 employees.

The current price is $4.19 with a P/E ratio of -x and P/B of -x.

ROE is -145.07% and operating margin is -1488.31%. Annual revenue is $3M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Camp4 Therapeutics Corp. (CAMP) Stock Forecast 2026 $4.19 — Price, Financials & Analyst Targets | Alpha Lenz